NCT03863886 Endoscopic Ultrasound Determines Disease Activity in Crohn's Disease And Ulcerative Colitis Status UNKNOWN Phase NA
NCT03849599 A Study to Evaluate the Safety of PRV-300 in Adult Subjects With Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE1
NCT03847467 Pilot and Feasibility Study of 2'-FL as a Dietary Supplement in IBD Patients Receiving Stable Maintenance Anti-TNF Therapy Status RECRUITING Phase PHASE1/PHASE2
NCT03843385 Transfer of FRozen Encapsulated Multidonor Stool Filtrate for Active Ulcerative COlitis Status RECRUITING Phase PHASE3
NCT03839680 Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis Status UNKNOWN Phase N/A
NCT03836612 Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT03835780 The Risk of Venous Thromboembolism in Systemic Inflammatory Disorders: a United Kingdom (UK) Matched Cohort Study Status COMPLETED Phase N/A
NCT03832400 Safety and Efficacy of Microbial Ecosystem Therapeutic-2 (MET-2) in Patients With Ulcerative Colitis (UC) Status COMPLETED Phase PHASE1
NCT03824561 Special Drug-Use Surveillance Study on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] Status COMPLETED Phase N/A
NCT03824418 The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis Status COMPLETED Phase N/A
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO Status RECRUITING Phase PHASE1
NCT03809728 IDENTIFICATION OF PROGNOSTIC AND PREDICTIVE BIOMARKERS IN INFLAMMATORY BOWEL DISEASE Status RECRUITING Phase NA
NCT03808506 Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis Status WITHDRAWN Phase N/A
NCT03804931 Fecal Microbiota Transplantation for Ulcerative Colitis Status RECRUITING Phase PHASE2/PHASE3
NCT03802214 Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy Status TERMINATED Phase N/A
NCT03798691 Immunogenicity of Herpes Zoster Subunit Vaccine in Inflammatory Bowel Disease Patients Treated With Vedolizumab Status COMPLETED Phase PHASE4